These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 3841996)

  • 1. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
    Tamaki N; Kusunoki T; Matsumoto S
    Ther Hung; 1985; 33(1):13-21. PubMed ID: 3841996
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 3. [Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine].
    Tamaki N; Matsumoto S
    Nihon Rinsho; 1985 Feb; 43(2):376-8. PubMed ID: 2987571
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic approach to TIA and acute cerebral stroke in geriatric patients using a platelet aggregation inhibiting and vasoactive drug].
    Cucinotta D; Monica C; Silvestrini C; Ceccato S; Cocchi C
    G Clin Med; 1979 Apr; 60(4):301-9. PubMed ID: 488589
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
    Ishchenko MM; Shkrobot SI; Borak VT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1160-4. PubMed ID: 3673409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
    Burtsev EM; Shprakh VV; Savkov VS
    Ross Med Zh; 1992; (2):41-3. PubMed ID: 1643337
    [No Abstract]   [Full Text] [Related]  

  • 7. Open-labeled phase III clinical trials with vinpocetine in Japan.
    Ebi O
    Ther Hung; 1985; 33(1):41-9. PubMed ID: 3915913
    [No Abstract]   [Full Text] [Related]  

  • 8. [The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
    Bagoly E; Fehér G; Szapáry L
    Orv Hetil; 2007 Jul; 148(29):1353-8. PubMed ID: 17631470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cavinton in the treatment of acute stroke.
    Kovács L
    Ther Hung; 1985; 33(1):50-7. PubMed ID: 3841999
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of patients with initial manifestations of cerebral circulation insufficiency in vasomotor dystonias].
    Kanareĭkin KF; Manvelov LS
    Klin Med (Mosk); 1992; 70(5-6):56-60. PubMed ID: 1434406
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ethyl apovincaminate on the cerebral circulation. Studies in patients with obliterative cerebral arterial disease.
    Solti F; Iskum M; Czakó E
    Arzneimittelforschung; 1976; 26(10a):1945-7. PubMed ID: 1037221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vinpotropile in the treatment of cerebral vascular diseases].
    Filimonov VA; Kliueva VN; Kondrasheva IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(2):58-60. PubMed ID: 18689000
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E; Di Lorenzo L; De Pergola G
    G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial dyscirculatory encephalopathy in middle-aged and elderly patients (problems of early diagnosis and therapy)].
    Man'kovskiĭ NB; Mints AIa; Karaban' IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):16-20. PubMed ID: 2718657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheoencephalographic and psychological studies with ethyl apovincaminate in cerebral vascular insufficiency.
    Hadjiev D; Yancheva S
    Arzneimittelforschung; 1976; 26(10a):1947-50. PubMed ID: 1037222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
    Burtsev EM; Shprakh VV; Savkov VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):39-44. PubMed ID: 3364094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trial of using Cavinton in cerebrovascular disorders].
    Shtok VN; Eremeeva SV
    Klin Med (Mosk); 1982 Oct; 60(10):39-42. PubMed ID: 6757560
    [No Abstract]   [Full Text] [Related]  

  • 19. Examinations of the relative fluidity in cerebrovascular disease patients.
    Szobor A; Klein M
    Ther Hung; 1992; 40(1):8-11. PubMed ID: 1585286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of kavinton on bronchial tonus in bronchial asthma patients].
    Karashurov SE
    Eksp Klin Farmakol; 1994; 57(6):35-6. PubMed ID: 7756957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.